EPO and Iron deficiency anemia: This reduction in GalnT3 mRNA may contribute to an increase in FGF23 cleavage under conditions characterized by elevated erythropoietin, such as iron deficiency anemia, inflammation, or exogenous treatment with synthetic erythropoietin.